The Clinical Network administers the Clinical Trials Management Scheme. It's been in operation since 1988 and retrospectively awards funding to hospitals coordinating clinical trials.
Over this time Cancer Council Victoria has provided nearly $15 million to support clinical trials research in Victoria. Currently 41 clinical trials sites (hospitals) across Victoria receive support. The purpose of this funding is to grow clinical trial capacity by financially supporting clinical trial Data Managers.
In return for this funding sites submit comprehensive data on types of trials, recruitment figures and full time equivalent employees (FTE) working in clinical trials research. This is the only comprehensive collection of such data undertaken annually in Victoria. The amount each site receives is based on the amount of patients recruited into the trials.
Currently the CTMS only funds treatment intervention trials. These are trials relating to radiotherapy, chemotherapy and surgery.
Cat Parker, Projects Coordinator Clinical Trials manages this project.
AYA cancer patients have poorer survival outcomes in comparison to other age cohorts for a number of cancers. With clinical trials significantly contributing to our understanding of disease states and the method by which new treatments ultimately become available for patients, it is prudent to examine AYA clinical trial participation due to these considerations. In recent years the Clinical Network has collected data to estimate the state-wide rate of AYA participation in oncology clinical trials in Victoria, and identify any important trends.